Statutory Rules
1975 No. 148
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1975.*
WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953-1975 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of the National Health Act 1953-1975 unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1975, namely the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:
NOW THEREFORE I, THE GOVERNOR-GENERAL of Australia, acting with the advice of the Executive Council, hereby make the following Regulations under the National Health Act 1953-1975.
Dated this twenty-ninth day of July, 1975.
JOHN R. KERR
Governor-General.
By His Excellency's Command,
D. EVERINGHAM
Minister of State for Health.
_______
Amendment of the National Health (Pharmaceutical Benefits) Regulations†
Commencement.
1. These Regulations shall come into operation on 1 August 1975.
* Notified in the Australian Government Gazette on 31 July 1975.
† Statutory Rules 1960, No. 17, as amended to date. For previous amendments of the National Health (Pharmaceutical Benefits) Regulations see footnote † to Statutory Rules 1975, No. 50 and see also Statutory Rules 1975, No. 50.
First, Second, Third, Fourth, and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules substituted:—
FIRST SCHEDULE Regulation 10
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in pharmaceutical benefits
1 Acetarsol 2 Acetomenaphthone 3 Acetomenaphthone Tablets 4 Acetrizoic Acid 5 Alcohol Dehydrated 6 Alcohol 95% 7 Allopurinol 8 Almond Oil 9 Aloes 10 Alprenolol Hydrochloride 11 Aluminium Hydroxide Tablets 12 Aluminium Phosphate Gel 13 Aluminium Phosphate Tablets 14 Aluminium Phosphate Gel Dried 15 Amethocaine Hydrochloride 16 Amodiaquine Tablets 17 Amphetamine Sulphate 18 Amphetamine Sulphate Tablets 19 Amylobarbitone Sodium Tablets 20 Antazoline Hydrochloride 21 Antazoline Tablets 22 Antimony Sodium Tartrate 23 Antimony Sodium Tartrate Injection 24 Apomorphine Hydrochloride 25 Apomorphine Injection 26 Arachis Oil 27 Aspirin and Caffeine Tablets 28 Aspirin and Codeine Tablets 29 Aspirin and Codeine Tablets Soluble 30 Aspirin Phenacetin and Codeine Tablets 31 Aspirin Phenacetin and Codeine Tablets Soluble 32 Azathioprine 33 Bacillus Calmette-Guerin Vaccine 34 Barbitone Sodium Tablets 35 Barium Sulphate 36 Belladonna Herb 37 Bendrofluazide 38 Benzhexol Hydrochloride 39 Benzyl Alcohol 40 Betamethasone Sodium Phosphate Tablets 41 Bethanidine Sulphate 42 Bisacodyl Tablets 43 Bupivacaine Hydrochloride 44 Busulphan 45 Butobarbitone 46 Butylated Hydroxyanisole 47 Butylated Hydroxytoluene 48 Caffeine Hydrate 49 Calciferol Solution 50 Calcium Aminosalicylate 51 Camphor 52 Caraway 53 Carbamazepine 54 Carbenoxolone Sodium 55 Carbimazole 56 Carbon Dioxide 57 Carbromal | 58 Cardamom Fruit 59 Cascara 60 Castor Oil 61 Catgut, Sterilised Surgical 62 Cellulose, Oxidised 63 Cetomacrogol 1000 64 Cetylpyridinium Chloride 65 Chlorambucil 66 Chlorcyclizine Hydrochloride 67 Chlordiazepoxide Capsules 68 Chlordiazepoxide Hydrochloride 69 Chlorhexidine Gluconate Solution 70 Chlorhexidine Hydrochloride 71 Chlormerodrin (297Hg) Injection 72 Chloroform 73 Chloroquine Phosphate 74 Chloroquine Phosphate Injection 75 Chloroquine Sulphate 76 Chlorothiazide 77 Chlorotrianisene 78 Chlorotrianisene Capsules 79 Chlorphenesin 80 Chlorproguanil Hydrochloride 81 Chlorproguanil Tablets 82 Chlorpropamide 83 Chlorthalidone 84 Choline Theophyllinate Tablets 85 Cinchocaine Hydrochloride 86 Cinnamon 87 Clofibrate 88 Clomiphene Citrate 89 Clomiphene Tablets 90 Cochineal 91 Colchicine 92 Colchicum Corm 93 Colchicum Liquid Extract 94 Colchicum Tincture 95 Colistin Tablets 96 Colophony 97 Concentrated Peppermint Water 98 Coriander 99 Coriander Oil 100 Corticotrophin 101 Corticotrophin Injection 102 Corticotrophin Gelatin Injection 103 Corticotrophin Zinc Injection 104 Cortisone Acetate 105 Cresol 106 Crotamiton 107 Cyanocobalamin 108 Cyanocobalamin (57Co) 109 Cyanocobalamin (58Co) 110 Cyclobarbitone Calcium 111 Cyclomethycaine Sulphate 112 Cyclopenthiazide 113 Cyclopentolate Hydrochloride 114 Cyclopropane 115 Cycloserine 116 Cycloserine Tablets 117 Dapsone 118 Deoxycortone Acetate |
First Schedule—continued
119 Deoxycortone Acetate Implants 120 Deoxycortone Acetate Injection 121 Dequalinium Acetate 122 Dequalinium Chloride 123 Desipramine Hydrochloride 124 Dexamphetamine Sulphate 125 Dextran 110 Injection 126 Dextromethorphan Hydrobromide 127 Dextromethorphan Tablets 128 Dextropropoxyphene Capsules 129 Dextropropoxyphene Napsylate 130 Dextrose 131 Diamorphine Hydrochloride 132 Diamorphine Injection 133 Diazepam Capsules 134 Dibromopropamidine Isethionate 135 Dichloralphenazone 136 Dichloralphenazone Tablets 137 Dichlorophen 138 Dichlorophen Tablets 139 Dichlorphenamide 140 Dicophane 141 Dienoestrol Tablets 142 Diethylcarbamazine Citrate 143 Diethylcarbamazine Tablets 144 Digitalis Leaf 145 Digitalis Prepared 146 Digitalis Tablets, Prepared 147 Digitoxin 148 Digitoxin Tablets 149 Dihydrocodeine Injection 150 Dihydrocodeine Tablets 151 Di-iodohydroxyquinoline Tablets 152 Diloxanide Furoate 153 Dilute Alcohols 154 Dimenhydrinate 155 Dimenhydrinate Injection 156 Dimenhydrinate Tablets 157 Dimercaprol 158 Dimethisterone 159 Dimethisterone Tablets 160 Diodone Injection 161 Diphenhydramine Injection 162 Diphtheria Vaccine 163 Diphtheria and Tetanus Vaccine 164 Diphtheria, Tetanus and Pertussis Vaccine 165 Diphtheria, Tetanus and Poliomyelitis Vaccine 166 Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine 167 Dipipanone Hydrochloride 168 Dipipanone Injection 169 Dodecyl Gallate 170 Domiphen Bromide 171 Dried Human Albumin 172 Dydrogesterone 173 Dydrogesterone Tablets 174 Edrophonium Chloride 175 Edrophonium Injection 176 Eltor Vaccine 177 Emetine and Bismuth Iodide 178 Emetine Hydrochloride 179 Emetine Injection 180 Erythromycin 181 Erythromycin Estolate Capsules 182 Ethacrynic Acid 183 Ethambutol Hydrochloride 184 Ethambutol Tablets
| 185 Ethchlorvynol 186 Ether Anaesthetic 187 Ether Solvent 188 Ethionamide 189 Ethionamide Tablets 190 Ethisterone 191 Ethisterone Tablets 192 Ethopropazine Hydrochloride 193 Ethotoin 194 Ethotoin Tablets 195 Ethyl Chloride 196 Ethyl Oleate 197 Ethylenediamine Hydrate 198 Eucalyptus Oil 199 Eugenol 200 Fenfluramine Hydrochloride 201 Fenfluramine Tablets 202 Ferric Citrate (89Fe) Injection 203 Ferrous Fumarate 204 Ferrous Succinate Tablets 205 Ferrous Sulphate Tablets 206 Fludrocortisone Acetate 207 Fluorescein Sodium 208 Fluoxymesterone 209 Fractionated Coconut Oil 210 Fractionated Palm Kernel Oil 211 Gallamine Triethiodide 212 Gallamine Injection 213 Gelatin Sponge, Absorbable 214 Gentamicin Sulphate 215 Gentian 216 Ginger 217 Globin Zinc Insulin Injection 218 Gold (198Au) Injection 219 Griseofulvin 220 Guanethidine Sulphate 221 Halothane 222 Helium 223 Heparin 224 Hexachlorophane 225 Hexylresorcinol 226 Histamine Acid Phosphate 227 Histamine Acid Phosphate Injection 228 Human Albumin 229 Human Albumin Fraction (Saline) 230 Human Albumin Fraction (Saline), Dried 231 Human Antihaemophilic Fraction, Dried 232 Human Blood, Whole 233 Human Fibrinogen, Dried 234 Human Fibrinogen for Isotopic Labelling, Dried 235 Human Normal Immunoglobulin Injection 236 Human Plasma, Dried 237 Human Red Blood Corpuscles, Concentrated 238 Human Serum, Dried 239 Human Thrombin, Dried 240 Hydrochlorothiazide 241 Hydrocortisone Hydrogen Succinate 242 Hydrocortisone Ointment 243 Hydroflumethiazide 244 Hydroxocobalamin 245 Hydroxychloroquine Sulphate 246 Hydroxyprogesterone Hexanoate 247 Hydroxyprogesterone Injection 248 Hyoscine Injection 249 Hyoscine Eye Ointment |
First Schedule—continued
250 Hyoscine Tablets 251 Hyoscyamus 252 Indigo Carmine 253 Indomethacin 254 Influenza Vaccine 255 Industrial Methylated Spirit 256 Intracutaneous Typhoid-paratyphoid A & B Vaccine 257 Inulin 258 Inulin Injection 259 Iodinated (126I) Human Albumin Injection 260 Iodinated (131I) Human Albumin Injection 261 Iodipamide Meglumine Injection 262 Iodised Oil Fluid Injection 263 Iopanoic Acid 264 Iopanoic Acid Tablets 265 Iophendylate Injection 266 Iothalamic Acid 267 Ipecacuanha 268 Ipecacuanha. Prepared 269 Isocarboxazid 270 Isocarboxazid Tablets 271 Isoniazid 272 Isopropyl Alcohol 273 Laevulose 274 Laevulose Injection 275 Lemon Peel, Dried 276 Levallorphan Injection 277 Levodopa 278 Levorphanol Injection 279 Levorphanol Tablets 280 Levorphanol Tartrate 281 Lignocaine and Adrenaline Injection 282 Liothyronine Sodium 283 Liquorice 284 Lithium Carbonate 285 Lymecycline 286 Lymecycline Capsules 287 Lymecycline and Procaine Injection 288 Macrisalb (131I) Injection 289 Macrogol 300 290 Macrogol 1540 291 Macrogol 4000 292 Magnesium Stearate 293 Maize Oil 294 Male Fern 295 Male Fern Extract 296 Maleic Acid 297 Mannitol 298 Measles Vaccine (Live Attenuated) 299 Mefenamic Acid 300 Mefenamic Acid Capsules 301 Meglumine Diatrizoate Injection 302 Meglumine Iothalamate Injection 303 Melarsoprol Injection 304 Melphalan 305 Melphalan Injection 306 Mepacrine Hydrochloride 307 Mepacrine Tablets 308 Mephentermine Injection 309 Mephentermine Sulphate 310 Meprobamate 311 Meprobamate Tablets 312 Mepyramine Injection 313 Mepyramine Maleate 314 Mepyramine Tablets 315 Mercaptopurine
| 316 Mersalyl Acid 317 Metaraminol Tartrate 318 Methandienone 319 Methaqualone 320 Methohexitone Injection 321 Methoin 322 Methoserpidine 323 Methoserpidine Tablets 324 Methoxyflurane 325 Methylcellulose 450 326 Methylamphetamine Hydrochloride 327 Methylamphetamine Injection 328 Methylamphetamine Tablets 329 Methyldopa 330 Methylergometrine Maleate 331 Methylprednisolone Tablets 332 Methylthiouracil 333 Methylthiouracil Tablets 334 Methyprylone 335 Methyprylone Tablets 336 Metronidazole 337 Metyrapone 338 Metyrapone Capsules 339 Morphine Sulphate Tablets 340 Nalorphine Hydrobromide 341 Nandrolone Decanoate 342 Nandrolone Phenylpropionate 343 Neostigmine Bromide 344 Nialamide 345 Nialamide Tablets 346 Niclosamide 347 Nicotinic Acid 348 Nicoumalone 349 Nikethamide 350 Nikethamide Injection 352 Nitrous Oxide 351 Nitrazepam 353 Norethandrolone 354 Norethandrolone Tablets 355 Noscapine 356 Novobiocin Calcium 357 Novobiocin Sodium 358 Novobiocin Tablets 359 Nux Vomica 360 Octyl Gallate 361 Oestradiol Benzoate 362 Oestradiol Benzoate Injection 363 Olive Oil 364 Opium 365 Opium, Powdered 366 Orange Peel, Dried Bitter 367 Orciprenaline Injection 368 Orphenadrine Hydrochloride 369 Oxygen 370 Oxyphenbutazone 371 Oxyphenbutazone Tablets 372 Oxyphencyclimine Hydrochloride 373 Oxytetracycline Tablets 374 Oxytocin Tablets 375 Paramethadione 376 Penicillamine 377 Penicillamine Hydrochloride 378 Pentagastrin 379 Pentagastrin Injection 380 Pentamidine Isethionate 381 Pentamidine Injection 382 Pentolinium Tartrate |
First Schedule—continued
383 Peppermint Oil 384 Percutaneous Bacillus Calmette-Guerin Vaccine 385 Perphenazine 386 Perphenazine Tablets 387 Pethidine Tablets 388 Phenacetin 389 Phenazocine Hydrobromide 390 Phenazocine Injection 391 Phenazocine Tablets 392 Phenelzine Sulphate 393 Phenelzine Tablets 394 Phenindamine Tartrate 395 Phenindione 396 Phenmetrazine Hydrochloride 397 Phenmetrazine Tablets 398 Phenobarbitone Sodium Tablets 399 Phenol and Glycerol Injection 400 Phenolphthalein Tablets 401 Phenoxybenzamine Capsules 402 Phenoxybenzamine Hydrochloride 403 Phenoxymethylpenicillin 404 Phenoxymethylpenicillin Calcium 405 Phenoxymethylpenicillin Potassium 406 Phentolamine Mesylate 407 Phentolamine Injection 408 Phenylephrine Injection 409 Phenylpropanolamine Hydrochloride 410 Phosphoric Acid 411 Phytomenadione Tablets 412 Piperazine Adipate Tablets 413 Piperazine Citrate 414 Piperazine Phosphate Tablets 415 Poldine Methylsulphate 416 Poliomyelitis Vaccine (Inactivated) 417 Poliomyelitis Vaccine (Oral) 418 Potassium Bromide 419 Potassium Chloride and Dextrose Injection 420 Potassium Chloride and Sodium Chloride Injection 421 Potassium Hydroxide 422 Potassium Nitrate 423 Practolol 424 Prednisolone Pivalate 425 Prednisolone Pivalate Injection 426 Prednisolone Sodium Phosphate Injection 427 Prednisone 428 Prilocaine Hydrochloride 429 Primaquine Phosphate 430 Probenecid 431 Procainamide Tablets 432 Procaine and Adrenaline Injection 433 Prochlorperazine Maleate 434 Prochlorperazine Mesylate 435 Procyclidine Hydrochloride 436 Progesterone 437 Progesterone Injection 438 Proguanil Hydrochloride 439 Promazine Hydrochloride 440 Promazine Injection 441 Promazine Tablets 442 Promethazine Theoclate 443 Propanidid 444 Propicillin Potassium 445 Propicillin Tablets 446 Propranolol Hydrochloride 447 Propyl Gallate
| 448 Propyliodone 449 Propyliodone Injection 450 Propyliodone Oily Injection 451 Propylthiouracil 452 Pyrazinamide 453 Pyridostigmine Bromide 454 Pyrimethamine 455 Pyroxylin 456 Quillaia 457 Quinine Bisulphate 458 Quinine Dihydrochloride 459 Quinine Dihydrochloride Injection 460 Quinine Hydrochloride 461 Quinine Sulphate 462 Rabies Antiserum 463 Rubella Vaccine (Live Attenuated) 464 Saccharin 465 Saccharin Sodium 466 Secbutobarbitone 467 L-Selenomethionine (76Se) Injection 468 Senna Fruit 469 Silver Nitrate, Toughened 470 Slow Lithium Carbonate Tablets 471 Slow Orphenadrine Citrate Tablets 472 Smallpox Vaccine, Dried 473 Soda Lime 474 Sodium Acetrizoate Injection 475 Sodium Aminosalicylate 476 Sodium Aurothiomalate 477 Sodium Bicarbonate Compound Tablets 478 Sodium Bromide 479 Sodium Calciumedetate 480 Sodium Chromate (83Cr) Solution 481 Sodium Citrate Tablets 482 Sodium Diatrizoate 483 Sodium Diatrizoate Injection 484 Sodium Fluoride 485 Sodium Fusidate Capsules 486 Sodium Hydroxide 487 Sodium Iodide (181I) Injection 488 Sodium Iodide (123I) Solution 489 Sodium Iodide (131I) Solution 490 Sodium Iodohippurate (131I) Injection 491 Sodium Iothalamate Injection 492 Sodium Lauryl Sulphate 493 Sodium Methyl Hydroxybenzoate 494 Sodium Pertechnetate (99mTc) Injection 495 Sodium Phosphate (83P) Injection 496 Sodium Propyl Hydroxybenzoate 497 Sodium Stibogluconate 498 Sodium Stibogluconate Injection 499 Sorbitol Injection 500 Spironolactone 501 Sterilisable Maize Starch 502 Stilboestrol 503 Stramonium 504 Strong Potassium Chloride Solution 505 Sulphadimethoxine 506 Sulphadimidine Injection 507 Sulphadimidine Sodium 508 Sulphamethoxydiazine 509 Sulphamethoxypyridazine 510 Sulphapyridine 511 Sulphinpyrazone 512 Sulphobromophthalein Sodium 513 Sulphomyxin Injection |
First Schedule—continued
514 Sulphomyxin Sodium 515 Sulthiame 516 Suxamethonium Bromide 517 Suxamethonium Bromide Injection 518 Suxamethonium Chloride 519 Suxamethonium Chloride Injection 520 Testosterone 521 Testosterone Implants 522 Testosterone Phenylpropionate Injection 523 Tetanus Antitoxin 524 Tetanus Vaccine 525 Tetanus and Pertussis Vaccine 526 Tetrachloroethylene 527 Tetrachloroethylene Capsules 528 Tetracycline Tablets 529 Thiambutosine 530 Thiomersal 531 Thiopentone Sodium 532 Thiopentone Injection 533 Thioridazine Hydrochloride 534 Thyroid 535 Thyroxine Sodium 536 Tolnaftate 537 Tolazoline Hydrochloride 538 Tolazoline Tablets 539 Tolbutamide 540 Tranylcypromine Sulphate 541 Tranylcypromine Tablets | 542 Triamterene Capsules 543 Trichloroethylene 544 Triclofos Tablets 545 Trimipramine Maleate 546 Tropicamide 547 Tuberculin, Old 548 Tuberculin Purified Protein Derivative 549 Tubocurarine Chloride 550 Tubocurarine Injection 551 Turpentine Oil 552 Typhoid and Tetanus Vaccine 553 Typhoid-paratyphoid A and B Vaccine 554 Typhoid-paratyphoid A and B and Tetanus Vaccine 555 Typhoid-paratyphoid A and B and Cholera Vaccine 555 Undecenoic Acid 557 Urea Injection 558 Vasopressin Injection 559 Vinyl Ether 560 Viomycin Sulphate 561 Viomycin Sulphate Injection 562 Viprynium Tablets 563 Vitamin A Ester Concentrate 564 Xenon (133Xe) Injection 565 Xylose 566 Yellow Fever Vaccine 567 Zinc Undecenoate 568 Zinc Undecenoate Ointment |
SECOND SCHEDULE Regulation 10 (3)
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
1 | Acepifylline....................... | — |
2 | Acetylsulphafurazole................. | — |
3 | Acetylcysteine...................... | — |
4 | Acrylic Resin...................... | — |
5 | Adrenaline Hydrochloride.............. | — |
6 | “ALBUMAID XP”................... | — |
7 | Alginic Acid Compound............... | — |
8 | Aluminium Sodium Silicate............. | — |
9 | Amino Acids....................... | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
10 | Aminocaproic Acid.................. | — |
11 | “AMINOGRAN”.................... | — |
12 | Amoxycillin Trihydrate................ | Purified Water, B.P., with Amoxycillin Trihydrate |
13 | Amphotericin...................... | Tetracycline, B.P.C., with a buffering agent and Amphotericin |
14 | Ampicillin........................ | — |
15 | Ampicillin Trihydrate................. | Purified Water, B.P., with Ampicillin Trihydrate |
16 | Antazoline Sulphate.................. | Naphazoline Nitrate with Antazoline Sulphate |
17 | Ascorbic Acid...................... | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Vitamin D and Ascorbic Acid |
|
| Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary |
|
| Ferrous Sulphate mixture Prescribes’ List |
|
| Ferrous Sulphate mixture Prescribes’ List Children’s Section |
18 | Bacitracin......................... | Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin |
19 | Bacitracin Zinc..................... | Neomycin Undecenoate with Bacitracin Zinc |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc |
20 | “ BANISH ”....................... | — |
21 | Belladonna Herb, Prepared.............. | Phenobarbitone with Belladonna Herb, Prepared |
22 | Belladonna, Dry Extract............... | Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna |
23 | Benzathine Penicillin................. | Procaine Penicillin with Benzylpenicillin Potassium and Benzathine Penicillin |
24 | Benzylpenicillin Sodium............... | Procaine Penicillin with Benzylpenicillin Sodium |
25 | Benzylpenicillin Potassium............. | Benzathine Penicillin with Procaine Penicillin and Benzylpenicillin Potassium |
26 | Betamethasone..................... | Betamethasone Acetate with Betamethasone |
27 | Betamethasone Acetate................ | Betamethasone with Betamethasone Acetate |
28 | Betamethasone Sodium Phosphate......... | — |
29 | Betamethasone Phosphate.............. | — |
30 | Bisacodyl......................... | Dioctyl Sodium Sulphosuccinate, B.P.C., with Bisacodyl |
31 | Brompheniramine Maleate.............. | — |
32 | Calciferol......................... | — |
33 | Calcium Di-Oxytetracycline............. | — |
34 | Calcium Lactate-Gluconate............. | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate |
35 | Capsicum Oleoresin.................. | Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954, and Capsicum Oleoresin |
36 | Carbachol......................... | Hypromellose 4500 with Carbachol |
37 | Carbinoxamine Maleate................ | — |
38 | Cascara Dry Extract.................. | Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954, and Cascara Dry Extract |
39 | Ceratonia, B.P.C. 1949................ | — |
40 | Chloramine, B.P.C................... | — |
41 | Chloramphenicol.................... | Polymyxin B Sulphate with Chloramphenicol |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
42 | Chloramphenicol Palmitate, B.P.C. | — |
43 | Chloramphenicol Stearate.............. | — |
44 | Chlorhexidine Gluconate............... | — |
45 | Chlorpheniramine Maleate.............. | — |
46 | Chlorpromazine Hydrochloride | — |
47 | Choline Theophyllinate................ | Guaiphenesin with Choline Theophyllinate |
48 | Clemastine Hydrogen Fumarate.......... | — |
49 | Clemizole Tannate................... | — |
50 | Cloxacillin Sodium................... | Purified Water, B.P., with Cloxacillin Sodium |
51 | Colistin Sulphate.................... | Neomycin Sulphate with Colistin Sulphate |
52 | Cortisone Acetate.................... | — |
53 | Cyclizine Hydrochloride............... | Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride |
54 | Cyproheptadine Hydrochloride........... | — |
55 | Danthron......................... | Dioctyl Sodium Sulphosuccinate, B.P.C., with Danthron |
56 | Demecarium Bromide................. | — |
57 | Demeclocycline Hydrochloride........... | Nystatin with Demeclocycline Hydrochloride |
58 | Dexamethasone..................... | Framycetin Sulphate with Gramicidin and Dexamethasone |
59 | Dexamethasone Metasulphobenzoate....... | Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate |
60 | Dexchlorpheniramine Maleate........... | — |
61 | Dextropropoxyphene Hydrochloride....... | Paracetamol with Dextropropoxyphene Hydrochloride |
62 | Dextrose Polymer.................... | — |
63 | Diazepam......................... | — |
64 | Dicyclomine Hydrochloride............. | Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride |
65 | Dienoestrol........................ | — |
66 | Digoxin.......................... | — |
67 | Dihydrocodeine Tartrate............... | — |
68 | Dihydrotachysterol................... | — |
69 | Dimethicone, B.P.C................... | — |
70 | Dioctyl Sodium Sulphosuccinate, B.P.C...... | Bisacodyl with Dioctyl Sodium Sulphosuccinate, B.P.C. |
| Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C. | |
71 | Diphenhydramine Hydrochloride.......... | Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride |
72 | Diphenoxylate Hydrochloride............ | Atropine Sulphate with Diphenoxylate Hydrochloride |
73 | Diphenylpyraline Hydrochloride.......... | — |
74 | Diphtheria Vaccine Adsorbed............ | Diphtheria and Tetanus Vaccine Adsorbed |
|
| Diphtheria, Tetanus and Pertussis Vaccine, Adsorbed |
75 | Doxycycline Hydrochloride............. | — |
76 | Doxylamine Succinate................. | Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate |
77 | Ecothiopate Iodide................... | — |
78 | Ergometrine Maleate.................. | Oxytocin with Ergometrine Maleate |
79 | Ergotamine Tartrate.................. | Caffeine with Ergotamine Tartrate |
|
| Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate |
80 | Erythromycin Estolate................. | — |
81 | Erythromycin Stearate................. | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
82 | Ethinyloestradiol.................... | Ethynodiol Diacetate with Ethinyloestradiol |
|
| Lynoestrenol with Ethinyloestradiol |
|
| Megestrol Acetate with Ethinyloestradiol |
|
| Norethisterone Acetate with Ethinyloestradiol |
|
| Norgestrel with Ethinyloestradiol |
83 | Ethosuximide...................... | — |
84 | Ethynodiol Diacetate.................. | Ethinyloestradiol with Ethynodiol Diacetate |
|
| Mestranol with Ethynodiol Diacetate |
85 | Ferric Hydroxide.................... | — |
86 | Ferrous Aminoacetosulphate............ | — |
87 | Ferrous Succinate.................... | — |
88 | Fluclorolone Acetonide................ | — |
89 | Fluocinolone Acetonide................ | — |
90 | Fluocortolone Hexanoate............... | Fluocortolone Pivalate with Fluocortolone Hexanoate |
91 | Fluocortolone Pivalate................. | Fluocortolone Hexanoate with Fluocortolone Pivalate |
92 | Fluphenazine Hydrochloride............. | — |
93 | Flurandrenolone..................... | — |
94 | Folic Acid......................... | Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P. |
95 | Framycetin Sulphate.................. | Dexamethasone with Framycetin Sulphate and Gramicidin |
|
| Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate |
96 | Fusidic Acid....................... | — |
97 | “ GALACTOMIN, FOR ............... | — |
| MULA No. 17 ”..................... | — |
98 | “ GALACTOMIN, FOR-............... | — |
| MULA No. 19 ”..................... | — |
99 | Glucose and Ketone Indicator............ | — |
100 | Glucose Indicator, Blood............... | — |
101 | Glucose Indicator, Urine............... | — |
102 | “ GLUCOSE NUTRAMIGEN ”.......... | — |
103 | Goats’ Milk, Dehydrated............... | Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
104 | Goats’ Milk........................ | |
105 | Gramicidin........................ | Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin |
|
| Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin |
106 | Guaiphenesin, B.P.C.................. | Theophylline with Guaiphenesin, B.P.C. |
107 | Hexamine Mandelate................. | — |
108 | Hydrocortisone..................... | Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone |
|
| Neomycin Sulphate with Hydrocortisone |
|
| Natamycin with Neomycin Sulphate and Hydrocortisone |
109 | Hydrocortisone Acetate................ | Neomycin Sulphate with Hydrocortisone Acetate |
|
| Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate |
|
| Oxytetracycline Hydrochloride and Hydrocortisone Acetate |
110 | Hyoscine Hydrobromide............... | Hypromellose 4500 with Hyoscine Hydrobromide Papaveretum with Hyoscine Hydrobromide |
111 | Idoxuridine........................ | — |
112 | Ipecacuanha....................... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959, and Ipecacuanha |
113 | “ ISOMIL ”........................ | — |
114 | Isoprenaline Hydrochloride............. | — |
115 | Kanamycin Sulphate, B.P.C............. | — |
116 | “ KETOVITE ” Liquid................ | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
117 | Lauryldimethylbenzyl Ammonium Chloride | “ TERIC N8 ” with Lauryldimethylbenzyl Ammonium Chloride |
118 | Levallorphan Tartrate................. | Pethidine Hydrochloride with Levallorphan Tartrate |
119 | Lincomycin Hydrochloride............. | — |
120 | Locasol.......................... | — |
121 | Lofenalac......................... | — |
122 | Lynoestrenol....................... | Ethinyloestradiol with Lynoestrenol Mestranol with Lynoestrenol |
123 | Lypressin......................... | — |
124 | Magnesium Aluminium Hydroxide | — |
125 | Magnesium Chloride.................. | Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride |
126 | Magnesium Hydroxide, B.P.C. | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
|
| Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C. |
127 | Mebhydrolin Napadisylate, B.P.C. | — |
128 | Meclozine Hydrochloride............... | Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride |
129 | Medrysone........................ | — |
130 | Megestrol Acetate................... | Ethinyloestradiol with Megestrol Acetate |
131 | Meglumine........................ | Theophylline with Meglumine |
132 | Mestranol......................... | Ethynodiol Diacetate with Mestranol |
|
| Lynoestrenol with Mestranol |
|
| Norethisterone with Mestranol |
|
| Norethynodrel with Mestranol |
133 | Methacycline Hydrochloride | — |
134 | Methdilazine Hydrochloride | — |
135 | Methylprednisolone.................. | — |
136 | Morphine Tartrate................... | Tacrine with Morphine Tartrate |
137 | Nalidixic Acid, B.P.C.................. | — |
138 | Naphazoline Hydrochloride............. | — |
139 | Naphazoline Nitrate.................. | Antazoline Sulphate with Naphazoline Nitrate |
140 | Natamycin........................ | Neomycin Sulphate with Hydrocortisone and Natamycin |
141 | Neomycin Sulphate.................. | Hydrocortisone Acetate with Neomycin Sulphate |
|
| Hydrocortisone with Neomycin Sulphate |
|
| Colistin Sulphate with Neomycin Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate |
|
| Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate |
|
| Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate |
|
| Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate |
|
| Natamycin with Hydrocortisone and Neomycin Sulphate |
142 | Neomycin Undecenoate................ | Bacitracin Zinc with Neomycin Undecenoate |
143 | Neostigmine Methylsulphate | — |
144 | Nicotinamide....................... | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D |
145 | Nitrofurantoin...................... | — |
146 | Noradrenaline Acid Tartrate | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
147 | Norethisterone...................... | Mestranol with Norethisterone |
148 | Norethisterone Acetate................ | Ethinyloestradiol with Norethisterone Acetate |
149 | Norethynodrel...................... | Mestranol with Norethynodrel |
150 | Norgestrel......................... | Ethinyloestradiol with Norgestrel |
151 | Nortriptyline Hydrochloride............. | — |
152 | Nystatin.......................... | Tetracycline, B.P.C., with a buffering agent and Nystatin |
|
| Demeclocycline with Nystatin |
|
| Tetracycline Hydrochloride with Nystatin |
|
| Gramicidin with Neomycin Sulphate, Triamcinolone Acetonide and Nystatin |
|
| Oxytetracycline Dihydrate with Nystatin |
153 | Octatropine Methylbromide | — |
154 | Orciprenaline Sulphate................ | — |
155 | Oxytetracycline Dihydrate.............. | Nystatin with Oxytetracycline Dihydrate |
156 | Oxytetracycline Hydrochloride, B.P. | Polymyxin B Sulphate with Oxytetracycline Hydrochloride, B.P. |
|
| Hydrocortisone Acetate with Oxytetracycline Hydrochloride, B.P. |
157 | Oxethazaine....................... | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C., and Oxethazaine |
158 | Oxytocin......................... | Ergometrine Maleate with Oxytocin |
159 | Pancreatin | — |
160 | Pancreatin Enzyme, 4 times U.S.N.F.XIII strength | — |
161 | Papaveretum, B.P.C................... | Hyoscine Hydrobromide with Papaveretum, B.P.C. |
162 | Pentobarbitone...................... | Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone |
163 | Pericyazine........................ | — |
164 | Pertussis Vaccine.................... | Diphtheria, Tetanus and Pertussis Vaccine Adsorbed |
165 | Pethidine Hydrochloride............... | Levallorphan Tartrate with Pethidine Hydrochloride |
166 | Phenethicillin Benzathine............... | — |
167 | Phenethicillin Potassium............... | Purified Water, B.P., with Phenethicillin Potassium |
168 | Pheniramine Maleate................. | — |
169 | Phenoxymethylpenicillin (Benzathine or Hydrabamine salt) | — |
170 | Phenytoin, B.P.C..................... | — |
171 | Pholcodine........................ | — |
172 | Pipenzolate Bromide.................. | — |
173 | Pituitary (Posterior Lobe), Powdered, B.P.C. | — |
174 | “ PK AID I ”....................... | — |
175 | “ PK AID II ”...................... | — |
176 | Plasma Substitute (Polypeptide) | — |
177 | Polyisobutylene..................... | — |
178 | Polymyxin B Sulphate................. | Chloramphenicol with Polymyxin B Sulphate |
|
| Oxytetracycline Hydrochloride with Polymyxin B Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
|
| Propylene Glycol with Acetic Acid and Polymyxin B Sulphate |
|
| Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate |
|
| Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate |
|
| Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate |
179 | Polyvinyl Alcohol................... | Pilocarpine Nitrate and Polyvinyl Alcohol |
180 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
181 | Prednisolone....................... | — |
182 | Prednisolone Acetate................. | Phenylephrine Hydrochloride, B.P., with Prednisolone Acetate |
183 | Prednisolone Sodium Phosphate | — |
184 | “ PREGESTIMIL ”................... | — |
185 | Primidone......................... | — |
186 | Procaine Penicillin................... | Benzathine Penicillin with Benzylpenicillin Potassium and Procaine Penicillin |
|
| Benzylpenicillin Sodium with Procaine Penicillin |
187 | Promethazine Hydrochloride | — |
188 | Pseudoephedrine Hydrochloride.......... | — |
189 | Pyrantel Embonate................... | — |
190 | Pyridoxine Hydrochloride.............. | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride |
191 | “ PROSOBEE ”..................... | — |
192 | Riboflavine........................ | Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine |
193 | Salbutamol........................ | — |
194 | Salbutamol Sulphate.................. | — |
195 | “ SOBEE ”........................ | — |
196 | Sodium Acetate..................... | Sodium Chloride with Potassium Chloride, Magnesium Chloride, Sodium Gluconate and Sodium Acetate |
197 | Sodium Acid Citrate.................. | — |
198 | Sodium Carboxymethylcellulose.......... | Gelatin and Pectin with Sodium Carboxymethylcellulose |
199 | Sodium Gluconate................... | Sodium Chloride with Sodium Acetate, Potassium Chloride, Magnesium Chloride and Sodium Gluconate |
200 | Sodium Lactate..................... | Potassium Chloride with Anhydrous Dextrose and Sodium Lactate |
201 | Sodium Tauroglycocholate, B.P.C. 1954 | Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954 |
202 | Sorbitol.......................... | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
203 | “ SOYALAC ”..................... | — |
204 | Sterculia | — |
205 | Strychnine, B.P.C. 1959............... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959 |
206 | Sulphafurazole...................... | — |
207 | Sulphamethizole.................... | — |
208 | Sulphamethoxazole................... | Trimethoprim with Sulphamethoxazole |
209 | Sulphaphenazole, B.P.C................ | — |
210 | Surgical Cement.................... | — |
211 | Surgical Cement Solvent............... | — |
212 | Tacrine........................... | Morphine Sulphate with Tacrine |
|
| Morphine Tartrate with Tacrine |
213 | Terbutaline Sulphate.................. | — |
214 | “ TERIC N8 ”...................... | Lauryldimethylbenzyl Ammonium Chloride with “ TERIC N8 ” |
215 | Testosterone Decanoate................ | Testosterone Propionate, B.P., with Testosterone Phenylpropionate B.P., Testosterone Isocaproate and Testosterone Decanoate |
216 | Testosterone Isocaproate............... | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
217 | Testosterone Phenylpropionate | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
218 | Testosterone Propionate............... | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
219 | Tetanus Vaccine Adsorbed.............. | Diphtheria and Tetanus Vaccine Adsorbed |
|
| Diphtheria, Pertussis and Tetanus Vaccine Adsorbed |
220 | Tetracycline, B.P.C................... | Tetracycline, B.P.C., with a buffering agent |
|
| Tetracycline, B.P.C., with a buffering agent and Amphotericin |
|
| Tetracycline, B.P.C., with a buffering agent and Nystatin |
221 | Tetracycline Hydrochloride | Tetracycline Hydrochloride with Nystatin |
|
| Procaine Hydrochloride with Tetracycline Hydrochloride |
222 | Thiamine Hydrochloride............... | Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride |
223 | Thioridazine....................... | — |
224 | Thiotepa.......................... | — |
225 | Thonzonium Bromide................. | Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide |
226 | Thonzylamine Hydrochloride............ | Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate. Thonzonium Bromide and Thonzylamine Hydrochloride |
227 | Tiemonium Iodide................... | — |
228 | Triamcinolone Acetonide.............. | Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide |
229 | Triclofos Sodium.................... | — |
230 | Trifluoperazine Hydrochloride........... | — |
231 | Triglycerides Oil, Medium Chain | — |
232 | “ TRIGLYDE ”..................... | — |
233 | Trimeprazine Tartrate, B.P.C. | — |
234 | Trimethoprim...................... | Trimethoprim with Sulphamethoxazole |
235 | Triprolidine Hydrochloride............. | — |
236 | Urea............................ | — |
237 | Viprynium Embonate................. | — |
238 | Vitamin A........................ | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A |
239 | Vitamin D........................ | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D |
240 | “ ZERODOR ”..................... | — |
241 | “ ZOFF ”......................... | — |
THIRD SCHEDULE Regulation 11
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
1 Acepifylline 2 Acetazolamide Sodium 3 Acetohexamide 4 Acetylcholine Chloride 5 Acetylcysteine 6 Acetylsulphafurazole 7 Acidified Golden Syrup, A.P.F. 1955 8 Acriflavine, B.P.C. 1963 9 Acrylic Resin 10 Adrenaline Hydrochloride 11 " ALBUMAID XP " 12 Alginic Acid Compound 13 Almond Oil Volatile Bitter, B.P.C. 1959 14 Aloin, B.P.C. 15 Aloxiprin 16 Aluminium Acetate Solution, B.P.C. 17 Aluminium Aspirin 18 Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex 19 Aluminium Sodium Silicate 20 Amantadine Hydrochloride 21 Amaranth B.P.C. 1954 22 Ambenonium Chloride 23 Amiloride Hydrochloride 24 Aminacrine Hydrochloride, B.P. 1968 25 Amino Acids 26 Aminogran 27 Amitriptyline Embonate, B.P.C. 28 Ammonia Aromatic Spirit, B.P.C. 29 Ammonia Solution. Strong, B.P.C. 30 Ammonium Acetate Solution, Strong, B.P.C. 31 Ammonium Bicarbonate, B.P.C. 32 Amoxycillin Trihydrate 33 Angiotensin Amide 34 Antazoline Sulphate 35 Anthrax Antiserum 36 Anthrax Vaccine 37 Anti-Haemophilic Factor of Animal Origin 38 Atropine, B.P.C. 39 Bacitracin, B.P. 1968 40 “ BANISH ” 41 Benzalkonium Chloride 42 Benzoin Compound Tincture, B.P.C. 43 Betahistine Hydrochloride 44 Betamethasone Acetate 45 Betamethasone Phosphate 46 Bethanechol Chloride 47 Biperiden Hydrochloride 48 Bismuth Subgallate, B.P.C. 49 Black Snake Antivenene 50 Bleomycin Sulphate 51 Brompheniramine Maleate 52 Brown Snake Antivenene 53 Buchu Concentrated Infusion, B.P.C. 1954 54 Cade Oil, B.P.C. 55 Caffeine and Sodium Benzoate, B.P.C. 1954 56 Caffeine Citrate, B.P.C. 1959 57 Calcitonin 58 Calcium Di-Oxytetracycline 59 Calcium Folinate 60 Calcium Gluconogalactogluconate | 61 Calcium Lactate-Gluconate 62 Capsicum Ointment, B.P.C. 63 Capsicum Oleoresin, B.P.C. 64 Carbinoxamine Maleate 65 Cardamom Aromatic Tincture, B.P.C. 66 Cascara Elixir, B.P.C. 67 Catechu Tincture, B.P.C. 68 Ceratonia, B.P.C. 1949 69 Charcoal, B.P.C. 70 Chloramine, B.P.C. 71 Chloramphenicol Palmitate, B.P.C. 72 Chloramphenicol Sodium Succinate 73 Chlorhexidine Gluconate 74 Chlorinated Lime, B.P.C. 75 Cholestyramine 76 Clemastine Hydrogen Fumarate 77 Clemizole Hydrochloride 78 Clemizole Tannate 79 Clindamycin Hydrochloride 80 Clonidine Hydrochloride 81 Clopamide 82 Clorexolone 83 Coal Tar, B.P.C. 84 Coal Tar Solution, Strong, B.P.C. 85 Cochineal Tincture, B.P. 1948 86 Coconut Oil, B.P.C. 87 Colaspase 88 Colophony Ointment, B.P.C. 1959 89 Copper Sulphate, B.P.C. 90 Creosote, B.P.C. 1959 91 Cyclothiazide 92 Cycrimine Hydrochloride 93 Cytarabine Hydrochloride 94 Daunorubicin 95 Death Adder Antivenene 96 Debrisoquine 97 Demecarium Bromide 98 Dexamethasone Metasulphobenzoate 99 Dexamethasone Sodium Phosphate 100 Dexchlorpheniramine Maleate 101 Dextrose Polymer 102 Diazoxide 103 Dibenzepin Hydrochloride 104 Dihydroergotamine Mesylate 105 Dimethicone, B.P.C. 106 Dimethindene Maleate 107 Dioctyl Sodium Sulphosuccinate, B.P.C. 108 Diphenylpyraline Hydrochloride 109 Diphtheria and Tetanus Vaccine Adsorbed, B.P., Diluted 110 Diphtheria Vaccine Adsorbed, B.P., Diluted 111 Dipyridamole 112 Doxepin Hydrochloride 113 Doxylamine Succinate 114 Droperidol 115 Ephedrine, B.P.C. 116 Epicillin 117 Epicillin Sodium 118 Erythrityl Tetranitrate 119 Erythromycin Ethyl Succinate 120 Erythromycin Gluceptate 121 Erythromycin Lactobionate 122 Ethanolamine Oleate 123 Ethoxzolamide |
Third Schedule—continued
124 Ethylidene Dicoumarin 125 Ethylnoradrenaline Hydrochloride 126 Ethyloestrenol 127 Ferric Hydroxide 128 Ferrous Aminoacetosulphate 129 Ferrous Phosphate Compound, Syrup, B.P.C. 1968 130 Fluclorolone Acetonide 131 Flumethasone Pivalate 132 Fluorometholone 133 Fluorouracil Sodium 134 Fluphenazine Decanoate 135 Fluphenazine Enanthate 136 Flurandrenolone 137 Fusidic Acid 138 “ GALACTOMIN, FORMULA No. 17 ” 139 “ GALACTOMIN, FORMULA No. 19 ” 140 Gall and Opium Ointment, B.P.C. 1963 141 Gelsemium Tincture, B.P.C. 142 Ginger Syrup, B.P.C. 143 Glibenclamide 144 Glucagon Hydrochloride 145 Glucose and Ketone Indicator 146 Glucose Indicator—Blood 147 Glucose Indicator—Urine 148 “ GLUCOSE NUTRAMIGEN ” 149 Glycerophosphate Compound Syrup, A.P.F. 1964 150 Glycopyrronium Bromide 151 Glymidine 152 Goats’ Milk, Dehydrated 153 Goats’ Milk, Whole (Sterilised) 154 Gramicidin 155 Guaiphenesin, B.P.C. 156 Haemodialysis Solutions, B.P.C. 157 Hamamelis Liquid Extract, B.P.C. 158 Heparin Calcium 159 Hexamine Hippurate 160 Hexamine Mandelate 161 Hexocyclium Methylsulphate 162 Hydrallazine Hydrochloride 163 Hydrargaphen 164 Hydromorphone Hydrochloride 165 Hydroxyurea 166 Hyoscine Butylbromide 167 Hyoscine Methobromide 168 Hyoscyamus Liquid Extract, B.P.C. 169 Hypophosphorous Acid, Dilute, B.P.C. 1963 170 Hyperomellose 4500, B.P.C. 171 Ibuprofen 172 Ichthammol, B.P.C. 173 Influenza Vaccine—Sub Unit Type (Desoxycholate Treated) 174 Injection of Amino Acids with Sorbitol and Alcohol 175 Injection of Potassium Chloride with Sodium Lactate and Anhydrous Dextrose 176 Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Anhydrous Dextrose 177 Injection of Sodium Chloride with Sodium Lactate and Anhydrous Dextrose 178 Insect Allergen Extract—Bull Ant 179 Insect Allergen Extract—Honey Bee 180 Insect Allergen Extract—Jumper Ant 181 Insect Allergen Extract—Paper Wasp | 182 Insulin Injection Neutral, Specially Purified—Monocomponent 183 Insulin Injection, specially purified 184 Insulin Isophane Injection, specially purified 185 Insulin Injection, Special P (Pig) 186 Insulin Isophane Injection, Special P (Pig) 187 Insulin Zinc Suspension (Amorphous), Specially Purified Injection—Monocomponent 188 Insulin Zinc Suspension, Specially Purified Injection—Monocomponent 189 Intraperitoneal Dialysis Solutions, B.P.C. 190 Iron Polymaltose Complex 191 “ ISOMIL ” 192 Isoprenaline Hydrochloride, B.P.C. 193 Isopropamide Iodide 194 “ KETOVITE ” Liquid 195 “ KETOVITE ” Tablets 196 Lactulose 197 Lauryldimethylbenzyl Ammonium Chloride 198 Lavender Oil, Spike, B.P.C. 1968 199 Lead Subacetate Strong Solution, B.P.C. 200 Lemon Oil Terpeneless, B.P.C. 201 Lemon Tincture, B.P. 1958 202 Lipopancreatin 203 Lobelia Ethereal Tincture, B.P.C. 204 Locasol 205 Lofenalac 206 Lypressin 207 Magenta, B.P.C. 208 Magnesium-Aluminium Hydroxide 209 Magnesium Hydroxide, B.P.C. 210 Maphenide Acetate 211 Mebeverine Hydrochloride 212 Mebhydrolin Napadisylate, B.P.C. 1968 213 Mecamylamine Hydrochloride, B.P. 1968 214 Medroxyprogesterone Acetate 215 Medrysone 216 Mefruside 217 Mepenzolate Bromide 218 Mercuric Chloride, B.P.C. 219 Methdilazine Hydrochloride 220 Methenolone Acetate 221 Methsuximide 222 Methyclothiazide 223 Methylphenobarbitone, B.P.C. 1963 224 Methylprednisolone Acetate 225 Methylprednisolone Sodium Succinate 226 Methysergide Maleate 227 Metoclopramide Hydrochloride 228 Minocycline Hydrochloride 229 Mithramycin 230 Morphine Tartrate 231 Myrrh Tincture, B.P.C. 232 Nalidixic Acid, B.P.C. 233 Nandrolone Hexyloxyphenylpropionate 234 Naphazoline Hydrochloride 235 Natamycin 236 Neomycin Undecenoate 237 Norgestrel 238 Octatropine Methylbromide 239 Oestradiol Valerate 240 Oestrone, B.P.C. 1954 241 Orange Syrup, B.P.C.
|
Third Schedule—continued
242 Orange Tincture, B.P.C. 243 Oxazepam 244 Oxethazaine 245 Oxprenolol Hydrochloride 246 Oxycodone Pectinate 247 Oxymel, B.P.C. 248 Oxymetholone 249 Oxyphenonium Bromide 250 Oxytetracycline 251 Oxytocin 252 Pancreatin Enzyme, U.S.N.F. XIII 253 Pancrelipase 254 Papaveretum, B.P.C. 255 Paraffin Liquid Light, B.P.C 1963 256 Paramethasone Acetate 257 Pectin 258 Pempidine Tartrate, B.P. 1968 259 Penicillinase 260 Pentaerythritol Tetranitrate, diluted, B.P.C. 261 Pentazocine Lactate 262 Pentobarbitone 263 Pericyazine 264 Pheniramine Maleate 265 Pheniramine Para-Aminosalicylate 266 Phenol Ointment, B.P. 1948 267 Phenoxymethylpenicillin, Benzathine 268 Phenoxymethylpenicillin, Hydrabamine 269 Phensuximide, B.P.C 270 Phenytoin, B.P.C. 271 Phthalylsulphacetamide 272 Physostigmine, B.P.C. 273 Pilocarpine Hydrochloride, B.P.C. 274 Pipenzolate Bromide 275 Pituitary Hormone, Follicle-stimulating, Human 276 Pituitary Hormone, Growth, Human 277 Pituitary (Posterior Lobe) Powdered, B.P.C. 278 Pizotifen Malate 279 “ PK AID I ” 280 “ PK AID II ” 281 Plasma Substitute (Polypeptide) 282 Polyisobutylene 283 Polyoestradiol Phosphate 284 Polyvinyl Alcohol 285 Polyvinylpyrrolidone and Vinyl Acetate Copolymer 286 Potassium Chlorate, B.P.C. 287 Potassium Effervescent Tablets 288 Pralidoxime Iodide 289 Prednisolone Acetate 290 Prednisolone Steaglate 291 Prednisolone Tertiary Butyl Acetate 292 “ PREGESTIMIL ” 293 Prindolol 294 Procarbazine Hydrochloride 295 Prochlorperazine 296 Proflavine Hemisulphate, B.P.C. 297 Proscillaridin 298 “ PROSOBEE ” 299 Pumilio Pine Oil, B.P.C. 300 Pyrantel Embonate 301 Quillaia Tincture, B.P.C. 302 Quinethazone 303 Quinidine Bisulphate 304 Rabies Vaccine (Duck Type) 305 Rabies Vaccine (Serum Type) 306 Raspberry Syrup, B.P.C. 307 Rauwolfia Alkaloids | 308 Rauwolfia Serpentina, B.P.C. 309 Red Back Spider Antivenene 310 Rolitetracycline 311 Rosemary Oil, B.P.C. 312 Saccharin Tablets, B.P.C. 313 Salicylamide 314 Sea Wasp Antivenene 315 Secbutabarbitone Sodium 316 Senega, Concentrated Infusion, B.P.C. 317 Siberian Fir Oil, B.P.C. 1949 318 Silver Protein, B.P.C. 1968 319 Silver Protein Mild, B.P.C. 1968 320 Snake Bite Antivenene—Polyvalent 321 “ SOBEE ” 322 Sodium Carboxymethylcellulose 323 Sodium Gluconate 324 Sodium Hypochlorite Solution, Strong, B.P.C. 325 Sodium Lactate 326 Sodium Nitroprusside 327 Sodium Tauroglycocholate, B.P.C. 1954 328 Sorbide Nitrate 329 “ SOYALAC ” 330 Spectinomycin Dihydrochloride Pentahydrate 331 Squill Oxymel, B.P.C. 332 Squill Syrup, B.P.C. 333 Squill Tincture, B.P.C. 334 Stanolone 335 Staphylococcus Toxoid, B.P. 1968 336 Stearic Acid, B.P.C. 337 Sterculia, B.P.C. 333 Stilboestrol Diphosphate 339 Stone Fish Antivenene 340 Stramonium Liquid Extract, B.P. 1968 341 Streptokinase 342 Strychnine, B.P.C. 1959 343 Sulphaphenazole, B.P.C. 1968 344 Sulphasalazine 345 Sulphasymazine 346 Sulphurated Potash, B.P.C. 347 Sulphur Sublimed, B.P.C. 348 Surgical Cement 349 Surgical Cement Solvent 350 Tacrine 351 Taipan Antivenene 352 Tartrazine, B.P.C. 1954 353 Terbutaline Sulphate 354 " TERIC N8 " 355 Testosterone Decanoate 356 Testosterone Enanthate 357 Testosterone Isocaproate 358 Tetracycline, B.P.C. 359 Thiabendazole, B.P.C. 360 Thiethylperazine Malate 361 Thiethylperazine Maleate 362 Thioguanine 363 Thiopropazate Hydrochloride, B.P.C. 364 Thioridazine 365 Thonzonium Bromide 366 Thonzylamine Hydrochloride 367 Tiemonium Iodide 368 Tiger Snake Antivenene 369 Titanium Dioxide, B.P.C. 370 Tolazamide 371 Tolu Syrup, B.P.C. 372 Triethanolamine, B.P.C. 373 Triglycerides Oil, Medium Chain 374 “ TRIGLYDE ” 375 Trimeprazine Tartrate, B.P.C. |
Third Schedule—continued
376 Trimetaphan Camsylate, B.P. 1968 377 Trioxysalen 378 Trolnitrate Phosphate 379 Vanillin, B.P.C. 380 Vasopressin Tannate 381 Verapamil Hydrochloride | 382 Vitamin A 383 Vitamin D 384 “ ZERODOR ” 385 Zinc Gelatin, B.P.C. 1968 386 “ ZOFF ” |
FOURTH SCHEDULE Regulation 12
Additives
1 Acetone, B.P.C. 2 Alcohol (95%), B.P. 3 Arachis Oil, B.P. 4 Camphor, B.P. 5 Caramel Solution A.P.F. 6 Castor Oil, B.P. 7 Chlorhexidine Acetate, B.P.C. 8 Chlorhexidine Gluconate Solution, B.P. 9 Chloroform, B.P. 10 Cineole, B.P.C. 11 Citronella Oil, B.P.C. 12 Concentrated Anise Water, B.P.C. 13 Concentrated Cinnamon Water, B.P.C. 14 Concentrated Peppermint Water, B.P. 15 Dextrose, B.P. 16 Dilute Alcohols, B.P. 17 Ether, Anaesthetic, B.P. | 18 Ether, Solvent, B.P. 19 Eucalyptus Oil, B.P. 20 Honey, Purified, B.P.C. 21 Hypromellose 4500, B.P.C. 22 Industrial Methylated Spirit, B.P. 23 Linseed Oil 24 Maize Oil, B.P. 25 Methylcellulose 20, B.P.C. 26 Methylcellulose 4500, B.P.C. 27 Olive Oil, B.P. 28 Peppermint Oil, B.P. 29 Saccharin Sodium, B.P. 30 Sodium Thiosulphate, B.P.C. 31 Syrup of Pholcodine Citrate, B.P.C. 1959 32 Turpentine Oil, B.P. 33 Xylene, B.P.C. 1949 |
FIFTH SCHEDULE Regulation 14
Pharmaceutical Benefits the Prescribing of which is Subject to Conditions and Restrictions
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
1 | Acetylcysteine...................... | Bronchiectasis |
|
| Cystic fibrosis (mucoviscidosis) |
2 | Acrylic Resin...................... | Ileostomy or colostomy conditions |
3 | “ ALBUMAID XP ”.................. | Phenylketonuria |
4 | Alprenolol Injection, B.P............... | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm (aortic) |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
5 | Alprenolol Tablets, B.P................ | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm (aortic) |
|
| Hypertension |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
6 | Amantadine Hydrochloride............. | With the written authority of the Director-General, the treatment of Parkinson's disease caused otherwise than by treatment with a drug |
7 | (1) Aminocaproic Acid, B.P. | Treatment in hospital of patients suffering from severe haemorrhage associated with excessive fibrinolysis |
| (2) Aminocaproic Acid Injection, B.P. | |
8 | “ AMINOGRAN ”................... | Phenylketonuria |
9 | (1) Amoxycillin Trihydrate | Infections by susceptible organisms where they cannot be safely and effectively treated with sulphonamides, oral forms of benzylpenicillin, phenoxymethylpenicillin or phenethicillin |
| (2) Amoxycillin Trihydrate with Purified Water, B.P. | |
|
| Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organisms to be sensitive to amoxycillin or where the patient is sensitive to sulphonamides |
10 | (1) Ampicillin Capsules, B.P. | Infections by organisms sensitive to ampicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally— |
| (2) Ampicillin Injections and Tablets | |
| (3) Ampicillin Trihydrate, B.P. with Purified Water, B.P. | |
| Benzylpenicillin | |
| Phenoxymethylpenicillin | |
|
| Phenethicillin |
|
| Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to ampicillin |
|
| Urinary tract infections where the patient is sensitive to sulphonamides |
11 | Ascorbic Acid Tablets, B.P. | Any disease or condition in a pensioner |
12 | Azathioprine....................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General— |
|
| Anaemia, autoimmune haemolytic |
|
| Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Continuing azathioprine therapy after discharge from an approved hospital |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
|
| Crohn's disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener's |
|
| Hepatitis, active, chronic |
|
| Lupus erythematosus, systemic |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Organ transplant |
|
| Pemphigus vulgaris |
|
| Polyarteritis nodosa |
|
| Pyoderma gangrenosum |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
13 | “ BANISH ”....................... | Ileostomy or colostomy conditions |
14 | Beclomethasone Dipropionate metered aerosol spray | Chronic intractable asthma requiring maintenance corticosteroids |
15 | Benzoin Compound Tincture, B.P.C., Aerosol Spray | Ileostomy or colostomy conditions |
16 | Betahistine Hydrochloride.............. | Meniere’s syndrome |
17 | Betamethasone Acetate with Betamethasone Injection | Alopecia areata |
| Granulomata, dermal | |
|
| Intra-articular use |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
|
| Uveitis |
18 | Bisacodyl Suppositories, B.P. | Any disease or condition in a paraplegic or quadriplegic patient |
|
| Any disease or condition in a pensioner |
19 | Bleomycin Sulphate.................. | Squamous cell carcinoma |
|
| Choriocarcinoma of the testis |
|
| Embryonal cell carcinoma of the testis |
|
| Lymphoma |
20 | (1) Calciferol, B.P. | With the written authority of the Director-General— |
| (2) Calciferol Tablets, Strong, B.P. | Hypoparathyroidism |
| Osteomalacia following gastrectomy, severe steatorrhoea or renal failure | |
|
| Vitamin D-resistant rickets |
21 | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate | Hypocalcaemia |
| Hypoparathyroidism | |
|
| Osteoporosis |
22 | Calcium Carbonate, B.P., with Citric Acid, B.P., Compound Effervescent Tablets | Hypocalcaemia |
| Hypoparathyroidism | |
| Osteoporosis | |
23 | Calcium Folinate.................... | Antidote to folic acid antagonists |
24 | Carbenicillin Sodium................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent |
25 | Carbenoxolone Tablets, B.P. | Gastric ulcer where a radiological examination or other tests have confirmed the presence of a gastric ulcer |
26 | (1) Cephalexin Capsules, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cephalexin Tablets, B.P. | |
| (3) Cephalexin, B.P. with Purified Water, B.P. | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalexin monohydrate is the most appropriate therapeutic agent |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
27 | Cephaloridine...................... | Infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent |
28 | Cephalothin Sodium.................. | Infections where positive bacteriological evidence confirms that cephalothin sodium is the most appropriate therapeutic agent |
29 | Charcoal Tablets.................... | Ileostomy or colostomy conditions |
30 | Chlorambucil Tablets, B.P.............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| |
|
| With the written authority of the Director-General— |
|
| Anaemia, autoimmune, haemolytic |
|
| Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Continuing chlorambucil therapy after discharge from an approved hospital |
|
| Crohn's disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener's |
|
| Hepatitis, active, chronic |
|
| Lupus erythematosus, systemic |
|
| Malignant disease including leukaemia |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Polyarteritis nodosa |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
31 | Chloramine Deodorant Tablets and Powder | Ileostomy or colostomy conditions |
32 | (1) Chloramphenicol Capsules, B.P. | Bacterial meningitis |
| Intraocular infections | |
| (2) Chloramphenicol Injections | Rickettsioses |
| Typhoid | |
| (3) Chloramphenicol Oral Suspension | The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient |
33 | Chlorotrianisene Tablets............... | Carcinoma of the prostate |
34 | (1) Chlorpromazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Chlorpromazine Injection, B.P. | Chorea |
| Hyperactive states of organic or toxic delirium | |
| (3) Chlorpromazine Tablets, B.P. | Major psychoses including— |
| Major organic psychoses including arteriopathic dementia | |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of 16 years |
35 | Cholestyramine..................... | With the written authority of the Director-General— |
|
| Bile salt ma absorption associated with ileal resection or proven ileal disease |
|
| Pruritus associated with partial biliary obstruction not responding to other therapy |
|
| Treatment of hypercholesterolaemia |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
36 | Clindamycin Hydrochloride | Gram-positive coccal infections where the infection cannot be safely and effectively treated with penicillin or a derivative of penicillin |
37 | Clofibrate......................... | With the written authority of the Director-General— |
|
| Diabetic retinopathy (exudative) |
|
| Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy |
|
| A second or subsequent course of treatment of hyperlipidaemia where significant lowering of serum triglyceride or serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report |
38 | (1) Cloxacillin Sodium, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cloxacillin Capsules, B.P. | |
| (3) Cloxacillin Sodium, B.P. with Purified Water, B.P. | With the written authority of the Director-General— |
| Infections where bacteriological evidence confirms the presence of penicillin-resistant staphylococci | |
|
| Osteomyelitis |
39 | (1) Codeine Phosphate with Aspirin Soluble Tablets | Any disease or condition in a pensioner |
| (2) Codeine Phosphate with Aspirin Tablets |
|
| (3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets |
|
| (4) Codeine Phosphate with Aspirin and Paracetamol Tablets (12mg-250mg-150 mg tablets, 10mg-250mg-250 mg tablets and 8 mg-250 mg-250 mg tablets) |
|
40 | Codeine Phosphate with Aspirin and Paracetamol Tablets 30 mg-225 mg-150 mg | Malignant neoplasia |
41 | Colistin Sulphomethate Sodium, B.P., for injection | Pyocyaneus infection, other gram-negative infections where no other drug is effective |
42 | Cyanocobalamin Injection, B.P | Pernicious anaemia and other proven Vitamin B12 deficiencies |
|
| Post-gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
43 | (1) Cyclophosphamide Tablets, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cyclophosphamide, B.P | With the written authority of the Director-General— |
|
| Anaemia, autoimmune, haemolytic |
|
| Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Continuing cyclophosphamide therapy after discharge from an approved hospital |
|
| Crohn's disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener’s |
|
| Hepatitis, active, chronic |
|
| Lupus erythematosus, systemic |
|
| Malignant disease, including leukaemia |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Pemphigus vulgaris |
|
| Polyarteritis nodosa |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
44 | Deodorant Detergent Solution (Lauryldimethylbenzyl Ammonium Chloride and “TERIC N8”) | Any disease or condition in a paraplegic or quadriplegic patient |
| Ileostomy or colostomy conditions | |
45 | Dexamphetamine Tablets, B.P. | With the written authority of the Director-General— |
| For the treatment of a patient who has not attained the age of twenty-one years and who is hyperkinetic as a result of brain damage | |
|
| Narcolepsy |
46 | (1) Dextromoramide Tablets, B.P. | Treatment in malignant neoplasia |
| (2) Dextromoramide Tartrate, B.P. |
|
47 | Dextrose Polymer................... | Phenylketonuria |
|
| Tube-feeding of infants with swallowing defects |
48 | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride | Vomiting in pregnancy |
49 | Dihydrotachysterol................... | With the written authority of the Director-General— |
|
| Hypoparathyroidism |
|
| Osteomalacia following gastrectomy, severe steatorrhoea or renal failure |
|
| Vitamin D-resistant rickets |
50 | Dimethicone Aerosol Spray | Ileostomy or colostomy conditions |
51 | Dimethicone Creams................. | Any disease or condition in a paraplegic or quadriplegic patient |
|
| Use with surgical appliances |
52 | (1) Dioctyl Sodium Sulphosuccinate | Any disease or condition in a paraplegic or quadriplegic patient |
| (2) Dioctyl Sodium Sulphosuccinate with Bisacodyl | Any disease or condition in a pensioner |
| (3) Dioctyl Sodium Sulphosuccinate with Danthron |
|
53 | Dipyridamole | Supplementing anticoagulants in— |
|
| Biopsy proven glomerulonephritis |
|
| Microangiopathic renal disease |
|
| Renal allograft |
|
| Patients with cardiac prosthesis |
54 | Droperidol........................ | Any disease or condition in a patient receiving treatment in a hospital |
55 | (1) Epicillin Capsules | Infections by organisms sensitive to epicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally— |
| (2) Epicillin Sodium | |
| (3) Epicillin with Purified Water, B.P. | |
|
| Benzylpenicillin |
|
| Phenoxymethylpenicillin |
|
| Phenethicillin |
|
| Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to epicillin |
|
| Urinary tract infections where the patient is sensitive to sulphonamides |
56 | Ethyloestrenol...................... | With the written authority of the Director-General— |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
57 | Fluoxymesterone Tablets, B.P. | Carcinoma of the breast |
|
| Hypogonadism |
|
| With the written authority of the Director-General— |
|
| Aplastic anaemias, proven |
|
| Osteoporosis |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
58 | (1) Fluphenazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Fluphenazine Tablets, B.P. | Chorea |
| (3) Fluphenazine Decanoate | Hyperactive states of organic or toxic delirium |
| (4) Fluphenazine Enanthate | Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
59 | (1) Folic Acid, B.P. | Cystic fibrosis |
| (2) Folic Acid Tablets, B.P., 5 mg | Haemolytic anaemia, chronic |
| Proven folic acid deficiency | |
|
| Sprue or the sprue-like syndrome |
60 | Framycetin Sulphate Tablets | Acute leukaemia during induction of remission with chemotherapy |
|
| Bowel sterilisation preparatory to major surgery |
61 | Frusemide Tablets, B.P., 500 mg | Renal failure |
62 | Fusidic Acid....................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence |
63 | “ GALACTOMIN FORMULA No. 17 ” | With the written authority of the Director-General— |
| Galactosaemia | |
|
| Conditions needing an extreme restriction of lactose in the diet of a patient under the age of 4 years |
64 | “ GALACTOMIN FORMULA No. 19 ” | With the written authority of the Director-General, glucose-galactose malabsorption |
65 | Gentamicin Injection, B.P............... | Any disease or condition in a patient receiving treatment in or as an approved hospital |
|
| With the written authority of the Director-General— |
|
| Infections where positive bacteriological evidence confirms that gentamicin sulphate is the most appropriate antibiotic |
|
| Septicaemia including suspected septicaemia |
66 | “ GLUCOSE NUTRAMIGEN ” | With the written authority of the Director-General— |
| Cows' milk allergy in children who have not attained the age of 6 years | |
|
| Cystic fibrosis (mucoviscidosis) |
|
| Galactosaemia |
|
| Lactose intolerance |
67 | Goats’ Milk, Dehydrated............... | With the written authority of the Director-General, cows’ milk allergy in children who have not attained the age of 6 years |
68 | Goats’ Milk, Whole (Sterilized) | With the written authority of the Director-General, cows’ milk allergy in children who have not attained the age of 6 years |
69 | Griseofulvin Tablets, B.P............... | With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood's Light |
70 | Halibut Liver Oil Capsules............. | Any disease or condition in a pensioner |
71 | Haloperidol....................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Chorea |
|
| Hyperactive states of organic or toxic delirium |
|
| Malignant neoplasia (late stage) |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
|
| Radiation sickness |
|
| Major psychoses including:— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
72 | Heparin Calcium.................... | Any disease or condition in a patient receiving treatment in a hospital |
73 | Hydrocortisone Acetate Injection, B.P. | Alopecia areata |
| Granulomata, dermal | |
|
| Intra-articular use |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
74 | Hydrocortisone Sodium Succinate Injection, 500 mg | Any disease or condition in a patient receiving treatment in a hospital |
75 | Hydroxocobalamin Injection, B.P. | Pernicious anaemia and other proven Vitamin B12 deficiencies |
|
| Post gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
76 | Ibuprofen......................... | Rheumatoid arthritis where salicylates are contraindicated or ineffective |
|
| Osteoarthritis where salicylates are contra-indicated or ineffective |
77 | (1) Idoxuridine Eye Drops | Infections caused by Herpes Simplex Virus or by Vaccinia Virus |
| (2) Idoxuridine Eye Ointment | |
78 | Influenza Vaccine................... | For prophylaxis of— |
|
| children who have attained the age of 1 year but have not attained the age of 5 years |
|
| pensioners |
|
| persons suffering from any severe debilitating disease, chronic heart disease or chronic pulmonary disease |
79 | Insulin Injection Neutral, Specially Purified—Mono-component | Insulin resistance due to antibodies or disabling local reactions |
80 | Insulin Zinc Suspension (Amorphous). Specially Purified Injection—Mono-component | Insulin resistance due to antibodies or disabling local reactions |
81 | Insulin Zinc Suspension, Specially Purified Injection—Monocomponent | Insulin resistance due to antibodies or disabling local reactions |
82 | “ ISOMIL ”....................... | With the written authority of the Director-General— |
|
| Cows’ milk allergy in children who have attained the age of 6 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
83 | Kanamycin Injection, B.P............... | Infections where positive bacteriological evidence confirms that kanamycin sulphate is the most appropriate antibiotic |
|
| Septicaemia, including suspected septicaemia |
84 | (1) “ KETOVITE ” Liquid | With the written authority of the Director-General— |
| (2) “ KETOVITE ” Tablets............. | Galactosaemia |
|
| Persistent monosaccharide intolerance |
|
| Phenylketonuria |
|
| Tyrosinosis (hereditary) |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
85 | Lactulose......................... | Hepatic coma or pre-coma (chronic portosystemic encephalopathy) |
86 | (1) Levodopa Capsules, B.P. | With the written authority of the Director-General, treatment of Parkinson’s Disease |
| (2) Levodopa Tablets, B.P. | |
87 | (1) Lignocaine Hydrochloride, B.P., Injection | Cardiac arrhythmias |
| (2) Lignocaine Hydrochloride Injection, B.P. |
|
88 | (1) Lincomycin Hydrochloride B.P. | Osteomyelitis |
| (2) Lincomycin Capsules, B.P. |
|
89 | Lincomycin Injection, B.P.............. | Gram-positive coccal infections where these cannot be safely and effectively treated with penicillin or a derivative of penicillin |
|
| Gram-negative anaerobic infections |
90 | Lithium Carbonate Tablets, B.P. | Manic depression |
91 | Locasol.......................... | With the written authority of the Director-General— |
|
| Hypercalcaemia in children who have not attained the age of 2 years |
|
| Osteopetrosis |
92 | Lofenalac......................... | Phenylketonuria |
93 | Maphenide Acetate.................. | Treatment, in a hospital, of burns |
94 | Medroxyprogesterone Acetate Tablets, 2.5 mg | Precocious puberty |
| Turner's syndrome | |
95 | Medroxyprogesterone Acetate Tablets, 10 mg | Malignant neoplasia |
| Precocious puberty | |
|
| Turner's syndrome |
95a | Medroxyprogesterone Acetate Tablets, 100mg | Malignant neoplasia |
96 | (1) Medroxyprogesterone Acetate Injections, 50 mg in 1 ml | Malignant neoplasia |
| Precocious puberty | |
| (2) Medroxyprogesterone Acetate Injections, 150 mg in 1 ml |
|
97 | Megestrol Acetate, B.P., with Ethinyloestradiol, B.P. | Treatment, including fertility control, of females with acne, hirsutism or sexual infantilism |
98 | (1) Methandienone Tablets, B.P. | With the written authority of the Director-General— |
| Osteoporosis | |
| (2) Methenolone Acetate............... | Patients on long-term treatment with corticosteroids |
99 | Methicillin Sodium, B.P., for injection | Proven or suspected staphylococcal septicaemia |
100 | (1) Methotrexate Tablets | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Methotrexate Injection | |
|
| With the written authority of the Director-General— |
|
| Continuing methotrexate therapy after discharge from an approved hospital |
|
| Malignant neoplasia |
|
| Pemphigus vulgaris |
|
| Severe intractable or extensive psoriasis |
101 | Methylprednisolone Acetate Retention Enema | Proctitis |
| Ulcerative colitis | |
102 | Methylprednisolone Acetate Injection | Intra-articular use |
| Intrathecal use | |
103 | Methyltestosterone Tablets, BP. 5 mg | Hypogonadism in patients who have not attained the age of 16 years |
| ||
104 | (1) Methyltestosterone Tablets, B.P., 25 mg or 50 mg | Carcinoma of the breast |
| Hypogonadism | |
| (2) Methyltestosterone, B.P. | Klinefelter's syndrome (seminiferous tubule dysgenesis) |
105 | Methysergide Maleate................ | Carcinoid syndrome |
|
| Prevention of disabling migraine when other treatment has failed |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
106 | Mithramycin.......................... | For use in a hospital for— |
|
| Inoperable testicular neoplasm |
|
| Symptomatic hypercalcaemia and hypercalcinuria associated with advanced neoplasia |
107 | Morphine Sulphate, B.P., with Tacrine Tablets | Severe intractable pain |
103 | Nalidixic Acid......................... | Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to nalidixic acid or where the patient is sensitive to sulphonamides |
109 | Nandrolone Decanoate.................... | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
110 | Nandrolone Hexyloxyphenyl Propionate | Carcinoma of the breast |
| With the written authority of the Director-General— | |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
111 | Nandrolone Phenylpropionate Injection, B.P. | Carcinoma of the breast |
| With the written authority of the Director-General— | |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
112 | Neomycin Sulphate Powder | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
113 | Neomycin Tablets, B.P.................... | Acute leukaemia during induction of remission with chemotherapy |
|
| Bowel sterilization preparatory to major surgery |
|
| Encephalopathy, hepatic |
|
| Enteropathogenic E. coli infections in infants |
114 | Nicotinic Acid Tablets, B.P. | Any disease or condition in a pensioner |
115 | (1) Nitrofurantoin Tablets, B.P. | Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to nitrofurantoin or where the patient is sensitive to sulphonamides |
| (2) Nitrofurantoin Oral Suspension | |
116 | Norethisterone Acetate, B.P., Tablets, 10 mg | Carcinoma of the breast |
| Carcinoma of the endometrium | |
117 | Norethisterone Acetate, B.P., Tablets, 2.5 mg | Endometriosis |
| Metropathia haemorrhagica | |
|
| Precocious puberty |
|
| Turner’s Syndrome |
118 | Norethisterone Tablets, B.P. 5 mg | Endometriosis |
| Metropathia haemorrhagica | |
|
| Precocious puberty |
|
| Turner's syndrome |
119 | Oxprenolol Hydrochloride Tablets | Dissecting aneurysm (aortic) |
| Hypertension | |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
120 | Oxprenolol Hydrochloride Injection | Idiopathic hypertrophic subaortic stenosis |
| Right ventricular outflow tract obstruction | |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
121 | Oxycodone Pectinate................. | Treatment in malignant neoplasia |
122 | Oxymetholone...................... | With the written authority of the Director-General— |
|
| Proven aplastic anaemias |
|
| Myelosclerosis |
123 | (1) Pancreatin, B.P. | Cystic fibrosis (mucoviscidosis) |
| (2) Pancreatin Enzyme 4X | Following pancreatico-duodenectomy |
| U.S.N.F.XIII | Pancreatic steatorrhoea |
| (3) Pancrelipase |
|
124 | (1) Paraffin Liquid Emulsion | Any disease or condition in a paraplegic or quadriplegic patient |
| (2) Paraffin Liquid Emulsion with Phenolphthalein | |
| Any disease or condition in a pensioner | |
125 | Penicillamine....................... | With the written authority of the Director-General— |
|
| Acute heavy metal intoxication |
|
| Cystinosis |
|
| Cystinuria with calculus formation |
|
| Haemoglobinuria, paroxysmal cold |
|
| Wilson's disease (hepatolenticular degeneration) |
126 | Pericyazine........................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Chorea |
|
| Hyperactive states of organic or toxic delirium |
|
| Major psychoses, including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of 16 years |
127 | Phenobarbitone Tablets, B.P., 60 mg and 100 mg | Epilepsy |
128 | Pizotifen Malate..................... | Prevention of migraine |
129 | (1) “ PK AID I ” | Phenylketonuria |
| (2) “ PK AID II ” |
|
130 | Polyisobutylene..................... | Ileostomy or colostomy conditions |
131 | Polymyxin B. Sulphate Powder | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
132 | Polyoestradiol Phosphate............... | Carcinoma of the breast |
|
| Carcinoma of the prostate |
133 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | Ileostomy or colostomy conditions |
134 | (1) Practolol Injection, B.P. | With the written authority of the Director-General— |
| (2) Practolol Tablets, B.P. | For the treatment of patients frequently disabled by attacks of angina in whom no evidence of cardiac failure is found, being patients in respect of whom other beta-blocking drugs should not be used because the patient suffers from bronchial asthma or any other condition associated with bronchospasm |
|
| For the treatment of patients suffering from serious arrhythmias, being patients in respect of whom other beta-blocking drugs should not be used because the patient suffers from bronchial asthma or any other condition associated with bronchospasm |
135 | Prednisolone Sodium Phosphate Retention Enema and Suppository | Ulcerative colitis |
| Proctitis |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
136 | (1) Prednisolone Acetate Injection | Intra-articular use |
| (2) Prednisolone Butyl Acetate Injection |
|
137 | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. | Corneal grafts |
| Uveitis | |
138 | “ PREGESTIMIL ”.................. | With the written authority of the Director-General— |
|
| Cystic fibrosis |
|
| Multiple disaccharidase deficiency |
139 | Prindolol Injection................... | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
140 | Prindolol Tablets.................... | Dissecting aneurysm (aortic) |
|
| Hypertension |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
141 | Promethazine Theoclate Tablets, B.P. | Vomiting in pregnancy |
142 | Propranolol Injection, B.P............... | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
143 | Propranolol Tablets, B.P................ | Dissecting aneurysm (aortic) |
|
| Hypertension |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found |
|
| Thyrotoxicosis |
144 | “PROSOBEE”...................... | With the written authority of the Director-General— |
|
| Cows’ milk allergy in children who have not attained the age of 6 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
145 | Pyridoxine Hydrochloride Tablets | Anaemia proved to be responsive to pyridoxine |
| Convulsions responsive to pyridoxine | |
|
| Homocystinuria |
|
| Primary hyperoxaluria |
|
| Radiation sickness |
|
| Sideroblastic (refractory) anaemia |
|
| Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy |
146 | Riboflavine Tablets.................. | Any disease or condition in a pensioner |
147 | Senna Tablets, B.P................... | Any disease or condition in a paraplegic or quadriplegic patient |
|
| Any disease or condition in a pensioner |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
148 | “ SOBEE ”....................... | With the written authority of the Director-General— |
|
| Cows’ milk allergy in children who have not attained the age of 6 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
149 | Sodium Carboxymethylcellulose with Pectin and Gelatin | Ileostomy or colostomy conditions |
150 | Sodium Fusidate.................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence |
151 | Sodium Tauroglycocholate with Cascara Dry Extract, B.P., Phenolphthalein, B.P., and Capsicum Oleoresin | Any disease or condition in a pensioner |
152 | “ SOYALAC ”..................... | With the written authority of the Director-General— |
|
| Cows’ milk allergy in children who have not attained the age of 6 years |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
153 | Spironolactone Tablets, B.P. | To supplement other diuretics when these have proved inadequate |
|
| Myasthenia gravis |
|
| Primary hyperaldosteronism |
|
| Secondary hyperaldosteronism |
154 | Stanolone........................ | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Osteoporosis |
|
| Patients on long-term treatment with corticosteroids |
155 | Sterculia......................... | Ileostomy or colostomy conditions |
156 | Stilboestrol Diphosphate............... | Carcinoma of the prostate |
157 | Streptokinase...................... | Any disease or condition in a patient receiving treatment in a hospital |
158 | (1) Surgical Cement.................. | Any disease or condition in a paraplegic or quadriplegic patient |
| (2) Surgical Cement Solvent | |
|
| For use with surgical appliances |
|
| Ileostomy or colostomy conditions |
159 | (1) Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate | Carcinoma of the breast |
| Hypogonadism | |
| Klinefelter's syndrome (seminiferous tubule dysgenesis) | |
| (2) Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
|
| (3) Testosterone Enanthate |
|
| (4) Testosterone Propionate Injection, B.P. |
|
160 | Tetracosactrin Acetate, B.P. | With the written authority of the Director-General— |
|
| Children who need long-term corticosteroid therapy but who are in danger of growth suppression as a result |
|
| Hypsarrhythmia |
|
| Multiple sclerosis, acute exacerbation |
|
| Status asthmaticus |
|
| Treatment of patients who are being withdrawn from long-term corticosteroid therapy |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
161 | Tetracosactrin Zinc Injection, B.P. | With the written authority of the Director-General— |
| Children who need long-term corticosteroid therapy but who are in danger of growth suppression as a result | |
|
| Hypsarrhythmia |
|
| Multiple sclerosis, acute exacerbation |
|
| Status asthmaticus |
|
| Treatment of patients who are being withdrawn from long-term corticosteroid therapy |
162 | Thiamine Hydrochloride Tablets, B.P. | Any disease or condition in a pensioner |
163 | Thioguanine....................... | Leukaemia |
164 | Thiopropazate Hydrochloride | Chorea |
|
| Oral dyskinesia |
|
| Phenothiazine-induced choreo-athetosis |
165 | (1) Thioridazine | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Thioridazine Tablets, B.P. | |
|
| Chorea |
|
| Hyperactive states of organic or toxic delirium |
|
| Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of 16 years |
166 | Triamcinolone Acetonide Injection | Alopecia areata |
| Granulomata, dermal | |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
167 | (1) Trifluoperazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Trifluoperazine Tablets, B.P. | Chorea |
| Hyperactive states of organic or toxic delirium | |
|
| Major psychoses including— |
|
| Major organic psychoses including arteriopathic dementia |
|
| Manic-depressive psychosis |
|
| Paranoid states |
|
| Schizophrenia |
|
| Senile dementia |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of 16 years |
168 | Triglycerides Oil, Medium Chain | Patients requiring a ketogenic diet for intractable childhood epilepsy |
|
| With the written authority of the Director-General, proven malabsorption |
169 | “ TRIGLYDE ”..................... | Patients requiring a ketogenic diet for intractable childhood epilepsy |
|
| With the written authority of the Director-General, proven malabsorption |
170 | Trioxysalen....................... | Vitiligo |
171 | Vancomycin Hydrochloride............. | Any disease or condition in a patient receiving treatment in a hospital |
172 | Verapamil Hydrochloride.............. | Cardiac arrhythmias |
24467/76—30
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
173 | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules | Any disease or condition in a pensioner |
174 | “ ZERODOR ”..................... | Ileostomy or colostomy conditions |
175 | “ ZOFF ”......................... | Any disease or condition in a paraplegic or quadriplegic patient |
|
| Ileostomy or colostomy conditions |
|
| For use with surgical appliances |